Noveris Health Sciences is trading at CA$1.14 (5.6%) up today, appearing to rise alongside a broadly constructive biotech tape despite a lack of fresh headlines directly tied to the move.
- The stock is rebounding modestly after experiencing significant volatility throughout late July and early August.
- Recent corporate updates include a July 17 announcement that the company joined the Biotechnology Innovation Organization and an April 29 update regarding a stake in a stem cell distribution business.